EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)

Zhenwang Ma, Hao Liang, Bingcheng Hu, Shaojie Cai, Dong Yan

International Journal of Molecular Medicine · 2023

DOI: 10.3892/ijmm.2023.5253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2023. Verfasst von Zhenwang Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Encephalopathy, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder that has a high incidence during the aging process and is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to motor dysfunctions and non‑motor symptoms. Impaired clearance and excessive accumulation of aberrantly modified proteins or damaged organelles, such as aggregated α‑synuclein and dysfunctional mitochondria, are regarded as the main causes of nigrostriatal neurodegeneration. As one of the major degradation pathways, autophagy can recycle these useless or toxic substances to maintain cellular homeostasis and it plays a crucial role in PD progression. MicroRNAs (miRNAs) are a group of small non‑coding RNA molecules that regulate gene expression by silencing targeted mRNAs. Recent studies have illustrated that autophagy‑regulating miRNA has been implicated in pathological processes of PD, including α‑synuclein accumulation, mitochondrial damage, neuroinflammation and neuronal apoptosis, which suggests that targeting autophagy‑regulating miRNAs may provide novel therapeutic strategies for this disease. The present review summarizes the role of autophagy in PD and emphasizes the role of miRNA‑mediated autophagy in PD, for the development of promising interventions in this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMicroRNAsHumansalpha-SynucleinAutophagyDopaminergic Neurons

Stichwörter der Autor:innen

Parkinson's diseaseautophagymiRNAstherapyα‑synuclein

Substanzen

MicroRNAsalpha-Synuclein

Autor:innen und Institutionen

  • Department of Encephalopathy, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China.
  • Graduate School of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China.
  • Department of Endocrinology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China.

Zitieren

APA

Ma, Z., Liang, H., Hu, B., Cai, S., & Yan, D. (2023). Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2023.5253

Vancouver

Ma Z, Liang H, Hu B, Cai S, Yan D. Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review). International Journal of Molecular Medicine. 2023. doi:10.3892/ijmm.2023.5253

BibTeX
@article{Ma2023,
  author = {Ma, Zhenwang and Liang, Hao and Hu, Bingcheng and Cai, Shaojie and Yan, Dong},
  title = {Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2023},
  doi = {10.3892/ijmm.2023.5253}
}
Kostenlos starten →